Rheumatoid arthritis (RA) is an autoimmune disease characterized by chronic inflammation, bone erosion, and cartilage destruction in the joints. It is increasingly being realized that inflammation might play an important role in inducing bone damage in arthritis. However, there is limited validation of this concept in vivo in well-controlled experimental conditions. We addressed this issue using the adjuvant arthritis (AA) model of RA. In AA, the draining lymph nodes are the main sites of activation of pathogenic leukocytes, which then migrate into the joints leading to the induction of arthritis. We tested the temporal kinetics of mediators of bone damage [e.g., receptor activator of nuclear factor kappa-B ligand (RANKL), osteoprotegerin (OPG) and osteopontin (OPN)] and inflammation (pro-inflammatory cytokines and chemokines) in the draining lymph node cells (LNC) at different phases ofAA, and then examined their inter-relationships. Our study revealed that, together with cytokines/chemokines, some of the mediators of bone remodeling are also produced in LNC. Various cytokines/chemokines showed distinct kinetics of expression as well as patterns of correlation with mediators of bone remodeling at different phases of the disease. Pro-inflammatory cytokines such as TNF-a are known to play an important role in bone damage. Interestingly, there was a positive correlation between TNF-a and RANKL, between RANKL and each of the 3 chemokines tested (RANTES, MIP-la, and GRO/KC), and between TNF-a and RANTES. Our results in the AA model lend support to the concept of osteo-immune crosstalk during the course of autoimmune arthritis.
Rheumatoid arthritis (RA) is a chronic autoimmune disease that primarily targets the joints, and is characterized by inflammatory synovitis mediated by leukocytes and proinflammatory cytokines secreted by them (1-5). Rat adjuvant arthritis (AA) is a model of polyarthritis, and it is widely used to study the pathogenesis of arthritis as well as to perform preclinical testing of anti-arthritic agents. AA can be induced in Lewis rats by subcutaneous (s.c.) immunization with heat-killed M tuberculosis H37Ra (Mtb). The draining lymph nodes are the sites ofactivation ofpathogenic leukocytes, which then migrate into the joints leading to the induction of arthritis. It is increasingly being realized that inflammation plays an important role in inducing bone damage in arthritis. Furthermore, the two processes share a common set of mediators, including certain cytokines and chemokines. This functional relationship between inflammation and bone damage is referred to as the "osteo-immune cross-talk", or "osteoimmunology" (6, 7) .
Although it is known that certain mediators of bone remodeling (e.g., receptor activator ofnuc1ear factor kappa-B ligand (RANKL) and osteopontin (OPN)) also playa role in immune responses by influencing antigen-presenting cell (APC)-T cell interactions, there is barely any information regarding the temporal kinetics of expression of these mediators in the draining lymph node cells (LNC) and their inter-relationships with the mediators of inflammation (cytokines and chemokines) in that tissue. The significance of the draining lymph nodes in the pathogenesis of arthritis is evident from studies showing that the disease can be adoptively transferred to syngeneic narve recipient rats via the draining LNC of arthritic rats (8) . Furthermore, the removal of lymph nodes during the incubation phase of AA prevents the subsequent development of AA in rats (9) . Also, we (10, 11) and others (12) have shown that study ofthe temporal cytokine profiles during AA can provide useful insights into the role of cytokine balance in disease susceptibility/ resistance.
To better understand the interplay between inflammation and bone damage, it is essential that not only the profiles but also the correlations between the levels of mediators of inflammation (cytokines and chemokines) and bone damage [RANKL, osteoprotegerin (OPG), OPN, etc.] are comprehensively examined. Furthermore, from the disease pathogenesis point of view, it is essential to know whether, and to what extent, the mediators of bone damage that are measured in the peripheral lymphoid tissue (the draining lymph nodes in this study) correlate with actual inflammation and bone damage in arthritic joints as measured by arthritic scores, histology, and bone histomorphometry. We have addressed these issues in the present study. We report here the expression profiles of defined mediators of bone remodeling, cytokines, and chemokines involved in arthritis, and their inter-relationships during the course of arthritis.
MATERIALS AND METHODS

Animals
Five to six week-old male Lewis (LEWlHsd) (RI"l') rats were purchased from Harlan Sprague-Dawley (HSD) (Indianapolis, IN, USA) and then maintained in the animal care facility of the University of Maryland School of Medicine, Baltimore. This study was carried out following recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The protocol (# 0511010) was approved by Institutional Animal Care and Use Committee of University of Maryland School of Medicine, Baltimore, MD. All efforts were made to minimize suffering to animals.
Induction and evaluation ofadjuvant arthritis (AA)
Lewis rats were immunized s.c. at the base of the tail with 1 mg/rat of heat-killed M tuberculosis H37Ra (Mtb) (Difco, Detroit, MI) in 200 ).1L of mineral oil (Sigma-Aldrich). The rats were assessed for signs of arthritis and graded for the severity of arthritis as described previously (13) . Briefly, the severity of arthritis was evaluated on the basis of erythema, swelling, and induration ofthe hind paws and graded on a scale of 0 to 4 as follows: 0 = no erythema or swelling, 1 = slight erythema or swelling of the ankle or wrist, 2 = moderate erythema and swelling at the wrist or ankle, 3 = moderate erythema and swelling at the wrist/metacarpals or ankle/metatarsals, 4 = severe erythema and swelling of the entire forepaw or hind paw. Different phases ofAA were labeled as follows: 0 day (naive), incubation (d 7), onset (d 12), peak (d 18),and regression/recovery (d 25).
Histological examination of hind paws of rats at different phases ofAA
The hind paws were harvested from rats on days 0, 7, 12, 18 and 25 after Mtb immunization and then immersed for 9 days in Cal-Ex Decalcifying solution CS51O-1D (Fisher Scientific, Fair Lawn, NJ). Thereafter, the paws were immersed in 70% ethanol for 5 days and then embedded in paraffin, sectioned serially using a microtome, and mounted on microscope slides in the Histology Core, UMB (14) . Thereafter, the sections were stained either with hematoxylin and eosin (H&E) or with Safranin-O (15) . Histopathological changes in the joints like synovial hyperplasia, pannus formation, and cartilage and bone damage were observed under a microscope (Nikon Eclips E800 Microscope, Nikon Industries Inc. Melville, NY) using the Spot Imaging Software, (Diagnostic Instruments Inc., Sterling Heights, MI) and digital images were obtained (14) .
Tartrate-resistant acid phosphatase (TRAP) staining
The unstained sections of hind paws (prepared as described above) were dehydrated in graded concentrations of ethanol and xylene, and fixed for 2 min using 3.7% formaldehyde. After washing with deionized water, the sections were incubated in the reaction mixture (Acid Phosphatase, Leukocyte (TRAP) Kit) at 37°C in a humid and light-protected incubator for 1 h as directed by the manufacturer. Thereafter, the sections were washed 3 times with distilled water, counter-stained with hematoxylin, observed under a microscope using the Spot Imaging Software, and digital images obtained.
Bone histomorphometry
Bone histomorphometry was performed on the TRAP-stained hind paw sections using the Osteomeasure Bone Histomorphometry system (Osteometries) linked to a Nikon Eclipse 50i inverted microscope and a Sony CCD video camera. Histomorphometric parameters used follow the recommended nomenclature of the American Society for Bone and Mineral research (16) . The analyses were performed on serial transverse sections through the talus (n= 4). Bone volume versus total tissue volume (BV/TV), the number of osteoclasts per tissue area (N.Oc/T.Ar), active resorption per bone surface area based on the ratio of osteoclast surface/bone surface area (Oc.SIBS), and the number of osteoclasts per bone perimeter (N.OcIB.Pm) were assessed.
Radiographic assessment of arthritis in hind paws ofrats
The severity of AA was assessed blindly at different phases ofthe disease by radiography. Highresolution digital radiographs (40 kV, 12 s) of hind limbs were performed on rats with a Faxitron Digital X-ray system (Faxitron X-Ray, Lincolnshire, IL, USA).
Preparation and antigenic restimulation of lymph node cells (LNC)
Mtb-immunized rats were euthanized at different phases of AA and their draining lymph nodes (paraaortic, inguinal and popliteal) were harvested (n= 3) (17) . A single-cell suspension of LNC was prepared in HL-l serum free medium (Ventrex Laboratories, Portland, ME) supplemented with 2 mM L-glutamine, 100 U/ml penicillin G sodium, and 100 ug/ml, streptomycin sulfate. These LNC were cultured (8 x 10 6 cells/well) in a 6-well plate (Coming Incorporated Coming, NY) for 24 h at 37°C in an atmosphere of 95% air and 5% CO 2 , Sonicated Mtb (l0 ug/ mL) was used for restimulation of LNC. Keyhole limpet hemocyanin (KLH) was used as the control antigen. Furthermore, LNC culture supernatant was harvested for testing by a Multiplex assay as elaborated below. In an independent set of experiments, LNC harvested from arthritic rats on day 18 were tested as described above but with the difference that IL-17 (100 ng/mL) was added to a subset of wells containing LNC. LNC culture supernatant was then tested by a Multiplex assay.
Determination ofchemokine/cytokineprotein expression by Multiplex immunoassay
Multiplex assays were performed at the Cytokine Core Facility (University of Maryland, Baltimore) using the Luminex 100TH analyzer (Luminex Corp., Austin, TX), and the levels of cytokines (as protein) in 24-h culture supernatant of LNC and serum were measured. The Rat chemokine 4-plex kit (Millipore) was used to measure regulated upon activation, normal T-cell expressed, and secreted (RANTES), monocyte chemotactic protein-l (MCP-l), macrophage inflammatory protein-la (MIP-la), growth regulated oncogene/ keratinocyte chemoattractant (GRO/KC). Similarly, the Rat cytokine 5-plex kit was used to measure TNF-a, IL-6, IL-17, IL-18 and Granulocyte-macrophage colonystimulating factor (GM-CSF). Single-plex and 3-plex kits were used to measure the levels of RANKL, OPGandOPN.
Statistical analysis
The data were expressed as mean ± SEM. Student's t-test and ANOVA were used to assess the significance of differences using GraphPad Prism version 4.0. A P value of < 0.05 was considered significant.
RESULTS
Clinical, histological and radiological characteristics of AA at different phases of the disease in the Lewis rat
The course of clinical AA. The severity of arthritis was graded in the hind paws. Swelling and erythema of hind paws appeared on days 10-12 after Mtb injection and then progressively increased with time post Mtb-injection until peak, followed by spontaneous regression of inflammation. The mean arthritic scores at different phases of AA are shown in Fig. l A. Based on the severity of arthritis, the course of AA had the following 5 phases in reference to in the articular facet and the surrounding area was detected. By day 25, soft tissue swelling was still present and bones were found to be fused, especially in the marginal area around the articular facet. The joint space was almost obliterated by then.
Histological examination ofhindpaws. H&Estained sections of the hind paws harvested on different days after Mtb immunization were examined ( Fig. lK-O) . No inflammation or tissue destruction was detected in histological sections on days 0 and 7. Pannus formation started appearing on day 12 and its extent continued to increase for the next few days. Marked synovial proliferation, mononuclear cell infiltration and destruction of articular bones were observed on day 12 and day 18 ofAA.
Histomorphometry of TRAP-stained paw sections
We examined the subchondral bone loss and osteoclast numbers in the talus of the hind paw joints of rats at different phases of AA using histomorphometry ( Fig. IB-E lU-Y).
The profiles of mediators of inflammation and bone damage at different phases ofAA
Pro-inflammatory cytokines. There was differential expression of cytokines at different phases of AA ( Fig. 2 top panel) . TNF-a and IL-6 showed a bell-shaped curve such that these cytokines were expressed at lower levels at early phase ofAA, at highest level at the peak phase, and then again at lower levels at the late phase of AA. IL-17 expression had an inverse bell-shaped curve, i.e., highest level of IL-17 was at the incubation phase, lowest level at the time of onset of AA, followed by an increase after day 18 onwards. However, IL-18 showed a gradually increasing profile with progression ofAA.
Chemokines. We tested 4 different chemokines in LNC culture supernate ( Fig. 2 bottom panel) . A bell-shaped curve was observed for the levels of RANTES and GRO/KC; a gradual increase from day 7, peak level at day 18, and a decline in levels thereafter. However, a biphasic curve was observed for MCP-l, with increased production at incubation phase (day 7), decreased production at onset (day 12), a slight increase at peak (day 18), followed by reduced expression at day 25. There was an increase in MIP-Ia at day 7 but no change thereafter.
Mediators of bone remodeling. The expression profiles ofthese mediators are shown in Fig. 3 . A bell-shaped curve was observed for RANKL with increased production at d 7, highest level at Onset (day 12), and then a gradual decline at later stages ofAA (Fig. 3) . In contrast, OPG was elevated at early stages but decreased after onset Fig. 3. (day 12). As expected, the RANKL/OPG ratio was low at early phase and then increased gradually in the late phase. There was no change in GM-CSF production until day 7, but slightly increased expression found at day 12, followed by high levels on day 18 and day 25. There was increased expression of OPN on day 0, followed by a decline thereafter.
Correlations among mediators of arthritic inflammation and bone remodeling. The correlation coefficient (r') was determined for a given pair of biomolecules from different subgroups (cytokines, chemokines and mediators of bone remodeling), and from the same subgroup. The results are summarized in Table I and described below.
Mediators ofbone remodeling and cytokines. A positive correlation was observed between RANKL and each of the pro-inflammatory cytokines (TNF-a, IL-6, IL-17, IL-18) tested (Table I ). In contrast, there was a negative correlation between OPG and TNF-a/IL-18. However, no significant correlation was observed between OPG and IL-6/IL-17. Interestingly, GM-CSF showed a pattern of correlation with the pro-inflammatory cytokines that was similar to RANKL but opposite to that ofOPG.
Mediators of bone remodeling and chemokines, RANKL/GM-CSF each showed a positive correlation with RANTES, MIP-1 a, and GROIKC. In contrast, OPG showed a negative correlation with both RANTES and GROIKC.
Cytokines vs chemokines. TNF-a, IL-6, IL-17 and IL-18 showed a positive correlation with all chemokines tested (RANTES, MCP-1, MIP-1 a, GROIKC), except for no significant correlation ofTNF-a and IL-18 with MCP-l. Arthritic scores vs mediators ofbone damage/ cytokines/chemokines. RANKL and GM-CSF showed a positive correlation with arthritic score. In contrast, OPG showed a negative correlation with the disease score. Among the cytokinesl chemokines, TNF-a, IL-6, IL-18, RANTES, and GRO/KC showed a positive correlation with arthritic scores.
IL-17-induced cytokines and chemokines in LNG. To assess the validity of some of the abovementioned correlations, we stimulated LNC with IL-17 in vitro and tested for the expression of cytokines and chemokines (Fig. 4) . Stimulation of LNC with Mtb in the presence of IL-17 resulted in increased production of cytokines such as TNF-a and IL-18, and it also elevated the levels of chemokines such as GRO/KC, MIP-l a, and RANTES~D ISCUSSION Immunization with heat-killed Mtb induces T cell-mediated arthritis (AA) in Lewis rats. Cells in the draining lymph nodes play an important role in the initiation and development of arthritis. The disease-inducing events start with a proinflammatory burst of immune activities in the draining lymphoid organs, generating a local pool of arthritogenic cells, which then migrate into the joints leading to arthritis in peripheral joints (8) . The inflammation thus induced triggers the production of mediators and the activation of subsets of cells (e.g., osteoclasts) involved in bone damage. This interplay among the mediators of inflammation and bone damage is referred to as the "osteo-immune crosstalk". Previous reports highlighting such a crosstalk have mostly been focused on the effect of a particular cytokine on the expression of a specific bone mediator, and that too, was tested on a single day in the course of a disease. In this context, there is limited information on the kinetics of mediators of bone damage in the draining LNC during the course of arthritis, or on the relationships 'between the kinetics of cytokines/chemokines versus that of the mediators of bone damage. We have addressed these critical issues in the present study.
Our study revealed at least two important aspects of the mediators of osteo-immune crosstalk in the draining LNC: 1) Together with cytokinesl chemokines, several mediators of bone remodeling are also produced in LNC; we propose that these mediators might be recruited to the target organs (joints) and thereby contribute to the disease process in AA. 2) Certain cytokines/chemokines show high correlation with mediators of bone resorption in early phase of AA, while others correlate well only in late phase of AA; however, a third group shows good correlation throughout the course of arthritis. These differential correlations might have functional implications.
Effect of cytokines on bone mediators of bone resorption
In arthritis, inflammation and tissue destruction result from complex cell-cell interactions. Cytokines such as TNF-a, IL-6 and IL-17 are the major proinflammatory mediators, which play an important role in inflammation and bone damage (18) (19) (20) (21) . Our results show a strong positive correlation between TNF-a and RANKL, supporting the existing literature (22, 23) . It is clear from our data that both TNF-a and RANKL are produced at incubation period ofAA and reach highest level at the onset of AA, followed by a slight decrease during the peak phase of AA. This trend also supports the likely synergistic effect of TNF and RANKL in up-regulating RANK expression as reported by others (23) . Other investigators have shown that IL-18 together with TNF-u stimulates osteoclastogenesis by inducing RANKL production in synovial T cells (24) . In comparison to RANKL, there was no significant correlation between OPG and any of the pro-inflammatory cytokines tested except for IL-18, which showed a strong negative correlation with AA. We suggest that cytokines produced in AA mediate bone damage predominantly via induction of RANKL instead of suppression of OPG during the disease course. A similar conclusion was reached when testing synovial-infiltrating cells (SIC) in our previously reported study (25) It has been reported that IL-17 can induce RANKL expression in the synovium, as tested at the peak phase of arthritis (26) . However, our study revealed only a weak positive correlation between IL-17 and RANKL in LNC during the disease course. This weak correlation might be due to the varying level of expression of IL-17 at different time points of the disease. We observed that IL-17 is produced at maximum level at early incubation phase and then the level drops at the onset and peak phases, followed by a sudden rise at the regression phase of AA. In contrast, RANKL reaches its maximum level at the onset of AA and then drops at the regression phase of the disease. Besides IL-17, IL-6 can also induce RANKL production (27) and this is supported by a strong correlation between these two mediators throughout the disease course. Another cytokine GM-CSF is known to aggravate arthritis (28) . In our study, GM-CSF increased with disease progression in AA, as did IL-18, but its levels did not correlate with any ofthe pro-inflammatory cytokines except for IL-18. As expected, we observed a strong negative correlation between RANKL and OPG, but a moderately negative correlation between GM-CSF and OPG. Furthermore, OPN showed a prominent decrease with progression ofAA.
Effect ofchemokines on mediators ofbone resorption
Chemokines play an important role in the development of arthritis. Chemokines may have either a direct or an indirect effect on bone mediators of bone resorption. The former by inducing them, the latter by either recruiting cells that produce them, or by regulating a cytokine which then can alter mediators of bone resorption. Chemokines such as RANTES, MCP-l, MIP-la and GRO/KC have been shown to be elevated in LNC and splenic adherent cells (SAC) of arthritic rats (29, 30) . In AA, elevated levels of RANTES are found in the peripheral blood at the onset of the disease, whereas MCP-l is first detected in the synovial tissue and later detected in the peripheral blood on day 18 (peak phase of AA) (31) . However, there is limited information on the expression kinetics of RANTES and MCP-l in the lymphoid tissue during the entire course of AA. Here we report that RANTES and MCP-l are expressed in the lymphoid tissue even before the onset of AA. The levels of RANTES and GRO/KC showed a gradual increase through the disease course until the peak phase, whereas MCP-1 had a biphasic expression profile. In comparison, MIP-la levels were almost constant after a sudden elevation at the incubation phase of AA. Further, RANTES positively correlated with both the disease score and the extent of bone damage. RANTES and MIP-Ia stimulate the development and motility of RANKL-dependent bone-resorptive osteoclasts (32) . In support of that report, our results show a strong positive correlation between RANKL and the 3 chemokines tested (RANTES, MIP-Ia, and GRO/ KC), whereas OPG failed to show any significant correlation with the expression of these chemokines. Further, RANKL induces RANTES and MCP-I production to promote osteoclast fusion and forms a platform for osteoclastogenesis (33) .
Effect ofcytokines on chemokines
Cytokines can effectively modulate the expression of certain chemokines. TNF-a showed a strong positive correlation with RANTES expression, whereas IL-17 had a weak correlation with RANTES. Though currently we do not know the significance of this correlation between IL-17 and RANTES, but it supports an earlier study where it was reported that IL-17 inhibited TNF-a-induced RANTES expression in synovial fibroblasts (34) . As per that study, levels ofTNF-a, IL-6, and IL-18 exhibited strong positive correlation with that of RANTES, MIP-I a and GRO/KC, indicating that cytokines and chemokines cooperate to propagate the disease process. The observed correlations were validated by our results ofin vitro stimulation ofLNC with IL-17. IL-17 not only induced the expression of TNF-a and IL-18, but also of chemokines such as RANTES, MIP-Ia and GRO/KC. In view of the above correlation, it is tempting to speculate a reverse effect, i.e., chemokines influencing the production of pro-inflammatory cytokines. However, to the best of our knowledge, there are no reports documenting the direct effects of chemokines on cytokine production in an arthritic milieu.
In conclusion, LNC expressed not only proinflammatory cytokines and chemokines but also mediators of bone remodeling during the course of AA. Statistical analysis showed a significant correlation between cytokines/chemokines and bone remodeling mediators, as well as between cytokines and chemokines. Our results lend support to the concept of osteo-immune crosstalk during the course of autoimmune arthritis in the AA model. These results are of direct relevance to human RA not only for advancing our understanding of the pathogenesis of autoimmune arthritis, but also for developing novel approaches for the treatment of arthritis.
